Rapid Pathogen Screening Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Rapid Pathogen Screening

Access the complete profile.

Rapid Pathogen Screening Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes	325413 In-Vitro Diagnostic Substance Manufacturing
Address	7227 Delainey Ct Lakewood Ranch, FL 34240

Note: Revenues for privately held companies are statistical evaluations.


Rapid Pathogen Screening's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Rapid Pathogen Screening's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Rapid Pathogen Screening is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Rapid Pathogen Screening Annual Revenue and Growth Rate

Rapid Pathogen Screening	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Rapid Pathogen Screening's revenues are gauged from an analysis of company filings.

Rapid Pathogen Screening's Income Statement (based on Industry Averages)

Rapid Pathogen Screening P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Rapid Pathogen Screening is developing and marketing. Rapid Pathogen Screening doesn't have any recent trademark applications, indicating Rapid Pathogen Screening is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
VIRADX Diagnostic preparations for medical purposes; Medical diagnostic test strips for measuring, testing, and analyzing blood and other bodily fluids	02/22/2022
SEPSIDX Diagnostic preparations for medical purposes; Medical diagnostic test strips for measuring, testing, and analyzing blood and other bodily fluids	04/01/2021
STEWART SHIPP Promoting antibiotic stewardship	08/06/2020

See all trademarks and details in the Full Report.

Market Share of Rapid Pathogen Screening's Largest Competitors

A competitive analysis shows these companies are in the same general field as Rapid Pathogen Screening, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Rapid Pathogen Screening. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
HOVEROUND	Bradenton, FL	100
RAPID PATHOGEN SCREENING	Lakewood Ranch, FL	16
BENZ RESEARCH & DEVELOPMENT	Sarasota, FL	14
BLACK PEARL VISION	Sarasota, FL	13
SARASOTA MEDICAL PRODUCTS	Sarasota, FL	11
HURRICANE MEDICAL	Bradenton, FL	7

Future Competition: Rapid Pathogen Screening's Fastest Growing Competitors

These companies are in the same general field as Rapid Pathogen Screening and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)